Inventor · disambiguated record
Pranjal Vaidya
Also filed as: VAIDYA PRANJAL
8 granted patents·2 pending applications·9 citations·filing 2018–2023
76Inventor score
Top patents by PatentIndex Score
10 records- 0185US10846367B2Predicting recurrence in early stage non-small cell lung cancer (NSCLC) with integrated radiomic and pathomic featuresUNIV CASE WESTERN RESERVE·Filed 2018·Granted Nov 24, 2020·6 cites·22 claims
- 0278US11676703B2Combination of radiomic and pathomic features in the prediction of prognoses for tumorsUNIV CASE WESTERN RESERVE·Filed 2020·Granted Jun 13, 2023·1 cites·27 claims
- 0372US2023326582A1Combination of radiomic and pathomic features in the prediction of prognoses for tumorsUNIV CASE WESTERN RESERVE·Filed 2023·Application pending·0 cites
- 0465US11574404B2Predicting recurrence and overall survival using radiomic features correlated with PD-L1 expression in early stage non-small cell lung cancer (ES-NSCLC)UNIV CASE WESTERN RESERVE·Filed 2019·Granted Feb 7, 2023·1 cites·20 claims
- 0562US11350901B2Recurrence prognosis and prediction of added benefit of adjuvant chemotherapy in early stage non-small cell lung cancer with radiomic features on baseline computed tomographyUNIV CASE WESTERN RESERVE·Filed 2018·Granted Jun 7, 2022·1 cites·20 claims
- 0656US12327349B2Fully automated assessment of coronary vulnerable plaque in coronary CT images using radiomic featuresSiemens Healthineers Ag·Filed 2022·Granted Jun 10, 2025·0 cites·25 claims
- 0755US11610304B2Predicting tumor prognoses based on a combination of radiomic and clinico-pathological featuresUNIV CASE WESTERN RESERVE·Filed 2020·Granted Mar 21, 2023·0 cites·20 claims
- 0845US11464473B2Distinguishing minimally invasive carcinoma and adenocarcinoma in situ from invasive adenocarcinoma with intratumoral and peri-tumoral textural featuresUNIV CASE WESTERN RESERVE·Filed 2019·Granted Oct 11, 2022·0 cites·20 claims
- 0944US2021110928A1Association of prognostic radiomics phenotype of tumor habitat with interaction of tumor infiltrating lymphocytes (tils) and cancer nucleiUNIV CASE WESTERN RESERVE·Filed 2020·Application pending·0 cites
- 1041US10839513B2Distinguishing hyperprogression from other response patterns to PD1/PD-L1 inhibitors in non-small cell lung cancer with pre-therapy radiomic featuresUNIV CASE WESTERN RESERVE·Filed 2019·Granted Nov 17, 2020·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →